# Genetic variation shapes the chromatin accessibility landscape and transcriptional responses in mouse adipose tissue

**Authors:** Juho Mononen, Mari Taipale, Marjo Malinen, Anna-Liisa Levonen, Anna-Kaisa Ruotsalainen, Luke Norton, Sami Heikkinen

PMC · DOI: 10.1371/journal.pgen.1011716 · 2026-01-16

## TL;DR

This study shows how genetic differences between two mouse strains affect chromatin accessibility and gene regulation in adipose tissue, offering insights into how non-coding genetic variants influence obesity-related diseases.

## Contribution

The study reveals that genetic variation directly alters chromatin accessibility and transcription factor binding in mouse adipose tissue, linking non-coding variants to gene regulation.

## Key findings

- Chromatin accessibility differences in adipose tissue are strain-specific and driven by genetic variation.
- Genetic variants at transcription factor binding sites correlate with changes in TF occupancy and chromatin accessibility.
- Differentially expressed genes are located near regions of altered chromatin accessibility caused by genetic variation.

## Abstract

Most of the disease associated genetic variants identified in genome wide association studies have been mapped to the non-coding regions of the genome. One of the leading mechanisms by which these variants are thought to affect disease susceptibility is by altering transcription factor (TF) binding. Even though inbred mouse strains have been commonly used to investigate polygenic diseases, less is known on how their genetic differences translate to the level of gene regulation and chromatin landscape. Here, we investigated how genetic variation affects chromatin accessibility in the epididymal white adipose tissue (eWAT) of C57BL/6J and 129S1/SvImJ mice, which are commonly used to study diet-induced obesity, fed either chow or high-fat diet. We show that differences in chromatin accessibility are almost exclusively strain-specific and driven by genetic variation. In addition, we integrate ATAC-seq (chromatin accessibility) and H3K27ac ChIP-seq (active regulatory regions) data to show that tissue-specific TF binding sites are commonly found in the active regulatory regions hosting TF motif altering variants in eWAT. Using footprint analysis, we also show that TF occupancy is consistent with TF binding motif scores at the genetically altered loci. In addition, we validate these findings by extending the analysis to ATAC-seq and H3K27ac ChIP-seq data obtained from the liver. We employ RNA-seq to show that differentially expressed genes are co-located with differentially accessible regions hosting genetic variants. Overall, our findings highlight the connection between differential chromatin accessibility and genetic variation across metabolically central tissues of a mouse model for polygenic obesity.

Most of the variants associated with polygenic diseases are outside the protein coding regions of the genome. In this study, we took benefit of the known genetic differences of two inbred mouse strains that are commonly used to study polygenic obesity to investigate the impact of the non-coding genetic variation on the chromatin landscape and the regulation of gene expression in the adipose tissue. Using several complementary sequencing and bioinformatic methods, we show that chromatin accessibility at genetically different transcription factor (TF) binding sites is associated with the strength of the altered TF binding motifs. We also identify the key TFs bound to the regions of genetically determined chromatin accessibility. We further show how the genetic effects propagate to the level of gene expression. Together, these findings give valuable insight into the mechanisms by which genetic variation affects gene regulation and provide future targets for research.

## Linked entities

- **Proteins:** SEP2 (K-box region and MADS-box transcription factor family protein)
- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** P9Ehs1 (protein, Chr 9, NIEHS 1) [NCBI Gene 109957], Cebpb (CCAAT/enhancer binding protein beta) [NCBI Gene 12608] {aka C/EBPbeta, CRP2, IL-6DBP, LAP, LIP, NF-IL6}, Hnf4a (hepatic nuclear factor 4, alpha) [NCBI Gene 15378] {aka HNF-4, Hnf4, Hnf4alpha, MODY1, Nr2a1, TCF-14}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, Wdtc1 (WD and tetratricopeptide repeats 1) [NCBI Gene 230796] {aka Gm695, adipose, adp}, Slc45a2 (solute carrier family 45, member 2) [NCBI Gene 22293] {aka Aim-1, Aim1, Dbr, Matp, Oca4, blanc-sale}, Jund (jun D proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16478] {aka Jund1}, Jdp2 (Jun dimerization protein 2) [NCBI Gene 81703] {aka Jundm2, Jundp2, TIF}, Paqr4 (progestin and adipoQ receptor family member IV) [NCBI Gene 76498] {aka 1500004C10Rik}, CTCF (CCCTC-binding factor) [NCBI Gene 10664] {aka CFAP108, FAP108, MRD21}, WT1 (WT1 transcription factor) [NCBI Gene 7490] {aka AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1}, CTCFL (CCCTC-binding factor like) [NCBI Gene 140690] {aka BORIS, CT27, CTCF-T, HMGB1L1, dJ579F20.2}, Sp1 (trans-acting transcription factor 1) [NCBI Gene 20683] {aka 1110003E12Rik, Sp1-1}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 83433] {aka TREM-2, Trem2a, Trem2b, Trem2c}, Ccl25 (C-C motif chemokine ligand 25) [NCBI Gene 20300] {aka A130072A22Rik, CKb15, Scya25, TECK}, Gbp2b (guanylate binding protein 2b) [NCBI Gene 14468] {aka Gbp-1, Gbp1, LIMIT, Mag-1, Mpa-1, Mpa1}, Ctcf (CCCTC-binding factor) [NCBI Gene 13018], Ets2 (Ets proto-oncogene 2, transcription factor) [NCBI Gene 23872] {aka Ets-2}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, Fdxr (ferredoxin reductase) [NCBI Gene 14149] {aka AR}, H3c7 (H3 clustered histone 7) [NCBI Gene 260423] {aka H3.2-221, H3c13, H3c14, H3c15, H3c2, H3c3}, Tcf7l2 (transcription factor 7 like 2, T cell specific, HMG box) [NCBI Gene 21416] {aka TCF4B, TCF4E, Tcf-4, Tcf4}, Irf4 (interferon regulatory factor 4) [NCBI Gene 16364] {aka IRF-4, LSIRF, NF-EM5, Spip}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, Spic (Spi-C transcription factor (Spi-1/PU.1 related)) [NCBI Gene 20728] {aka Prf, Spi-C}, Prr36 (proline rich 36) [NCBI Gene 73072], Snapc2 (small nuclear RNA activating complex, polypeptide 2) [NCBI Gene 102209] {aka 0610007H10Rik}, Cebpa (CCAAT/enhancer binding protein alpha) [NCBI Gene 12606] {aka C/ebpalpha, CBF-A, Cebp}, XCL1 (X-C motif chemokine ligand 1) [NCBI Gene 6375] {aka ATAC, LPTN, LTN, SCM-1, SCM-1a, SCM1}, Wt1 (WT1 transcription factor) [NCBI Gene 22431] {aka D630046I19Rik, Wt-1}, Stat5a (signal transducer and activator of transcription 5A) [NCBI Gene 20850] {aka STAT5}, Dars1 (aspartyl-tRNA synthetase 1) [NCBI Gene 226414] {aka 5730439G15Rik, Dars}, Stat6 (signal transducer and activator of transcription 6) [NCBI Gene 20852], Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}
- **Diseases:** obese (MESH:D009765), developmental deficits (MESH:D001289), fibrosis (MESH:D005355), liver disease (MESH:D008107), liver damage (MESH:D056486)
- **Chemicals:** sodium deoxycholate (MESH:D003840), LiCl (MESH:D018021), formaldehyde (MESH:D005557), N2 (MESH:D009584), SDS (MESH:D012967), lipid (MESH:D008055), fat (MESH:D005223), Igepal (-), PIPES (MESH:C008916), sucrose (MESH:D013395), digitonin (MESH:D004072), EDTA (MESH:D004492), CaCl2 (MESH:D002122), Triton X-100 (MESH:D017830), IGEPAL CA-630 (MESH:C010615), Tween-20 (MESH:D011136), KCl (MESH:D011189), H2O. (MESH:D014867), NaCl (MESH:D012965), OptiPrep (MESH:C044834), PBS (MESH:D007854), CO2 (MESH:D002245)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S12C, S12D, S11E, C-to-T, S10D, rs227674984, glycine for 5, M0544S
- **Cell lines:** 129S1/SvImJ — Mus musculus (Mouse), Embryonic stem cell (CVCL_C319), B6 — Homo sapiens (Human), Finite cell line (CVCL_L814), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12844536/full.md

---
Source: https://tomesphere.com/paper/PMC12844536